Officer Dennis Mulroy Files Intent to Sell $576K in Shares, Continues Recent Sales Pattern
ANAB has more than doubled off its 52-week low of $11.402.
Summary
An officer at AnaptysBio has filed to sell $576,000 in shares, adding to over $2.75 million in sales already executed this month, signaling continued insider distribution.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files Intent to Sell
Dennis Mulroy, an officer, filed a Form 144 to sell 10,000 shares valued at approximately $576,000.
-
Recent Insider Sales
This filing follows Mulroy's sale of 45,467 shares for gross proceeds of $2,752,623.04 in the past three months, with all sales occurring in May 2026.
-
Context of Corporate Actions
These sales occur after the company completed its biopharma spin-off in April and announced a $100 million share repurchase program on May 12, 2026.
Analysis · ANAB · Life Sciences
Dennis Mulroy, an officer, has filed a Form 144 indicating intent to sell an additional $576,000 worth of shares. This follows recent sales totaling over $2.75 million by Mulroy in May, occurring after the company's spin-off and a new share repurchase program. This pattern of significant insider selling by an officer could be interpreted negatively, especially as the company recently completed a spin-off and announced a share repurchase program.
At the time of this filing, ANAB was trading at $57.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.